Clinical Trial Update: Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional Therapy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating fondaparinux for treating pulmonary embolism has been withdrawn. The study aimed to assess whether fondaparinux could be che…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• Fondaparinux (fondaparinux)

Snippet

Sponsor: University of Minnesota | Conditions: Pulmonary Embolism | Phase 4 | Status: WITHDRAWN